Related Experiment Video
Updated: Jun 24, 2026
05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
Tumors that look for their springtime in APRIL
E Roosnek1, M Burjanadze, P Y Dietrich
1Division of Hematology, Geneva University Hospitals, Switzerland.
Critical Reviews in Oncology/Hematology
|March 17, 2009
Summary
Tumor necrosis factor family member, proliferation inducing ligand (APRIL), promotes cancer development. APRIL shows potential as a prognostic tool and therapeutic target for various cancers.
Area of Science:
- Oncology
- Immunology
Background:
- Proliferation inducing ligand (APRIL), a tumor necrosis factor family member, is produced by inflammatory cells.
- APRIL has been implicated in promoting the development of various cancers.
- Recent research highlights APRIL's role in solid tumors and hematological malignancies.
Purpose of the Study:
- To review the literature on the role of APRIL in cancer.
- To provide evidence for APRIL's utility as a prognostic tool.
- To explore APRIL as a potential cancer treatment target.
Main Methods:
- Literature review of recent studies on APRIL and cancer.
- Analysis of evidence supporting APRIL's prognostic value.
- Evaluation of APRIL's therapeutic potential in oncology.
Main Results:
- APRIL plays a role in tumor development and progression.
- Evidence suggests APRIL can serve as a prognostic biomarker.
- APRIL inhibition is a potential therapeutic strategy.
Conclusions:
- APRIL is implicated in the pathogenesis of various cancers.
- APRIL may serve as a valuable prognostic indicator.
- Targeting APRIL presents a promising avenue for cancer therapy.
Related Concept Videos
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...